Literature DB >> 30383902

Donor liver apoptosis is associated with early allograft dysfunction and decreased short-term graft survival after liver transplantation.

Zebin Zhu1,2,3, Yunhua Tang1,2,3, Shanzhou Huang1,2,3, Qiang Zhao1,2,3, Paul M Schroder4, Zhiheng Zhang1,2,3, Yixi Zhang1,2,3, Chengjun Sun1,2,3, Linhe Wang1,2,3, Weiqiang Ju1,2,3, Dongping Wang1,2,3, Zhiyong Guo1,2,3, Xiaoshun He1,2,3.   

Abstract

BACKGROUND: The clinical significance of apoptosis in assessing the quality of donor liver grafts remains unknown. AIMS: This study aimed to determine whether apoptosis in a donor liver is predictive of early allograft dysfunction (EAD) and graft survival after liver transplantation (LT).
METHODS: Donor liver specimens were analyzed for apoptosis using TUNEL assays. The prognostic factors for EAD were identified through logistic regression analyses, and a nomogram was developed.
RESULTS: The apoptosis index of donor livers in EAD patients was significantly higher than that of donors livers in non-EAD patients (median 5.3; interquartile range [IQR] 3.4 vs 3.5; 3.6, P < 0.001). Multivariate analyses identified the apoptosis index of the donor liver (HR = 6.927, P < 0.001) and five other characteristics as independent predictors of EAD. A nomogram built on these predictive variables showed good calibration and discriminatory abilities, with a c-index value of 0.847. The 30-day graft survival rates in the high apoptosis index (apoptosis index >4.4%) group were significantly lower than those in the low apoptosis index (apoptosis index ≤4.4%) group (84.4% vs 97.6%, P = 0.004).
CONCLUSIONS: Donor liver apoptosis plays a significant role in predicting EAD after LT. Furthermore, a high apoptosis index in the donor liver was associated with inferior graft survival in the short-term.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  apoptosis; early allograft dysfunction; graft loss; graft survival

Mesh:

Year:  2018        PMID: 30383902     DOI: 10.1111/ctr.13438

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  4 in total

1.  Early allograft dysfunction after liver transplantation with donation after cardiac death donors.

Authors:  Junbin Zhou; Qiang Wei; Shusen Zheng; Xiao Xu
Journal:  Hepatobiliary Surg Nutr       Date:  2019-10       Impact factor: 7.293

2.  Liver Ischemia and Reperfusion Induce Periportal Expression of Necroptosis Executor pMLKL Which Is Associated With Early Allograft Dysfunction After Transplantation.

Authors:  Shaojun Shi; Eliano Bonaccorsi-Riani; Ivo Schurink; Thierry van den Bosch; Michael Doukas; Karishma A Lila; Henk P Roest; Daela Xhema; Pierre Gianello; Jeroen de Jonge; Monique M A Verstegen; Luc J W van der Laan
Journal:  Front Immunol       Date:  2022-05-17       Impact factor: 8.786

3.  Weighted Gene Coexpression Network Analysis in Mouse Livers following Ischemia-Reperfusion and Extensive Hepatectomy.

Authors:  Wei Liu; Yongquan Shi; Tao Cheng; Ruixue Jia; Ming-Zhong Sun; Shuqing Liu; Qinlong Liu
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-30       Impact factor: 2.629

4.  Prospective, single-centre, randomised controlled trial to evaluate the efficacy and safety of ischaemia-free liver transplantation (IFLT) in the treatment of end-stage liver disease.

Authors:  Changjun Huang; Shanzhou Huang; Yunhua Tang; Qiang Zhao; Dongping Wang; Weiqiang Ju; Lu Yang; Jian Zhang; Linwei Wu; Maogen Chen; Zhiheng Zhang; Zebin Zhu; Linhe Wang; Caihui Zhu; Yixi Zhang; Chengjun Sun; Wei Xiong; Yuekun Shen; Xiaoxiang Chen; Yi Ma; Anbin Hu; Xiaofeng Zhu; Jian Rong; Changjie Cai; Zhiyong Guo; Xiaoshun He
Journal:  BMJ Open       Date:  2020-05-05       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.